HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dietary Supplement Field Activities Could Require $31.2 Mil. – CFSAN

This article was originally published in The Tan Sheet

Executive Summary

The Center for Food Safety & Applied Nutrition estimates it will need up to $31.2 mil. to support field activities by the fifth year of the center's Dietary Supplement Strategic Plan

You may also be interested in...



FDA Ginseng Labeling Enforcement Stressed In House Ag Approps Bill

FDA needs to take a more active approach to ensure that herbs that do not fall under the Panax genus are not labeled as "ginseng," the House Appropriations Committee states in its report on the FY 2003 Agriculture Appropriations bill

ANDA Bioequivalence Data Subject Of Upcoming FDA Proposed Rule

FDA expects to issue an advance notice of proposed rulemaking in November requiring ANDA applicants to include data from all bioequivalence studies conducted on a drug formulation with their application

CFSAN 10-Year Supplement Plan Costs Ready To Be Sent To Congress

FDA's Center for Food Safety & Applied Nutrition will send a completed cost analysis of its 10-year dietary supplements strategic plan to Capitol Hill within the next few weeks, CFSAN's John Ford said at the Food & Drug Law Institute annual education conference in Washington, D.C. April 19.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS130079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel